IMI is a public private partnership between the European Union and the pharmaceutical industry represented by EFPIA. With its 2 billion euro research programme, IMI aims to speed up the development of better and safer medicines for patients, and to boost pharmaceutical innovation in Europe.
This video explains the goal of IMI and includes an animated demonstration of the drug development process.
www.imi.europa.eu
Link to this comment:
All Comments (0)